RTSN · Retension Pharmaceuticals, Inc. · Documents
Market Cap
$134.81M
Shares
8.33M
Volume · Oct 21
76.35K
Avg daily vol (8 sessions)
235.95K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | Retension Pharmaceuticals, Inc. closed its initial public offering on October 13, 2026, after filing its Third Amended and Restated Certificate of Incorporation with Delaware on October 9, 2026; the amended bylaws also became effective immediately before the IPO closed. | 2026-10-13 | 2026-10-09 | |
| S-1/A | — | 2026-10-07 | — | |
| S-1/A | — | 2026-10-05 | — | |
| S-1 | — | 2026-09-18 | — |
Showing 1–4 of 4 filings